NCT07546058

Brief Summary

Background: Orthodontic miniscrews are widely used as temporary anchorage devices; however, failure remains a clinical concern. Bisphosphonates may enhance bone stability, but evidence on their local application is limited. Objective: To evaluate the effect of local subperiosteal zoledronic acid (ZA) injection on miniscrew survival and peri-miniscrew inflammation. Materials and Methods: This triple-blind, split-mouth randomized controlled trial included 68 patients requiring bilateral maxillary premolar extraction. Miniscrews were placed bilaterally, with one side randomly receiving a 0.5 mL solution of zoledronic acid at 1 mg/mL concentration and the contralateral side saline. Injections were administered weekly for three weeks. Orthodontic force (\~250 g) was applied 24 hours after final injection. The primary outcome was miniscrew survival at 6 months. Paired comparisons were analyzed using McNemar test, with odds ratios (ORs) and 95% confidence intervals (CIs).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 2, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 3, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2026

Completed
13 days until next milestone

First Posted

Study publicly available on registry

April 22, 2026

Completed
Last Updated

April 22, 2026

Status Verified

April 1, 2026

Enrollment Period

11 months

First QC Date

April 9, 2026

Last Update Submit

April 16, 2026

Conditions

Keywords

Orthodontic miniscrewsTemporary anchorage devicesBisphosphonatesZoledronic acidAnchorage reinforcement

Outcome Measures

Primary Outcomes (1)

  • Mobility

    Proportion of orthodontic miniscrews with no clinical mobility during follow-up, assessed by manual clinical examination

    6 months

Secondary Outcomes (1)

  • Peri-miniscrew inflammation

    6 months

Study Arms (2)

Intervention (Zoledronic Acid)

EXPERIMENTAL

zoledronic acid administered miniscrews

Drug: Zoledronic Acid

Placebo / Saline Group

PLACEBO COMPARATOR

saline administered miniscrews

Drug: Normal saline (0.9% sodium chloride)

Interventions

Zoledronic acid was prepared at a concentration of 1 mg/mL according to the manufacturer's instructions (ADMAC Pharmaceuticals). A volume of 0.5 mL was injected subperiosteally adjacent to miniscrews on the experimental side. Dose calculation was based on conversion from animal studies using the human equivalent dose (HED) formula.39,40 The calculated HED was 0.0216 mg/kg, corresponding to approximately 1.296 mg for a 60-kg individual. One week after placement, injections were administered weekly for three consecutive sessions.

Also known as: Bisphosphonate
Intervention (Zoledronic Acid)

Three local subperiosteal injections of sterile 0.9% saline solution were administered at the orthodontic miniscrew insertion sites, beginning one week after placement and repeated at weekly intervals for three consecutive sessions, serving as an inert control without pharmacological effect.

Placebo / Saline Group

Eligibility Criteria

Age17 Years - 28 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Mild to moderate skeletal Class II Division 1 malocclusion with full-cusp Class II molar relationship, ANB angle between 4° and 6°, normal maxilla-mandibular plane angle (25° ± 5°), and indication for first premolar extraction to reduce overjet.

You may not qualify if:

  • Periodontal disease or alveolar bone loss.
  • Craniofacial deformities.
  • Cleft lip or palate.
  • Impacted or missing teeth in the treatment area.
  • Systemic diseases or current medication affecting bone metabolism.
  • Poor gingival health.
  • Smoking or inadequate oral hygiene.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Latakia University

Latakia, Latakia Governorate, Syria

Location

Related Publications (5)

  • Feldmann I, Bondemark L. Orthodontic anchorage: a systematic review. Angle Orthod 2006;76:493-501.

    RESULT
  • Ganzer N, Feldmann I, Bondemarkc L. Anchorage reinforcement with miniscrews and molar blocks in adolescents: A randomized controlled trial. Am J Orthod Dentofacial Orthop 2018;154:758-67

    RESULT
  • Lee SJ, Ahn SJ, Lee JW, Kim SH, Kim TW. Survival analysis of orthodontic mini-implants. Am J Orthod Dentofacial Orthop. 2010;137:194-9

    RESULT
  • Moghaddam S, Mohammadi A, Behroozian A. The effect of sandblasting and acid etching on survival rate of orthodontic miniscrews: a split-mouth randomized controlled trial. Progress in Orthodontics 2021; 22:2.

    RESULT
  • Kloehn SJ. Orthodontics-force or persuasion. Angle Orthod 1953; 23:55-65

    RESULT

MeSH Terms

Interventions

Zoledronic AcidDiphosphonatesSaline SolutionSodium Chloride

Intervention Hierarchy (Ancestors)

OrganophosphonatesOrganophosphorus CompoundsOrganic ChemicalsImidazolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical PreparationsChloridesHydrochloric AcidChlorine CompoundsInorganic ChemicalsSodium Compounds

Study Officials

  • Shadi G Moawad, Ph.D

    Assistant Professor

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

April 9, 2026

First Posted

April 22, 2026

Study Start

December 1, 2024

Primary Completion

November 2, 2025

Study Completion

February 3, 2026

Last Updated

April 22, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations